Q2 2026 Earnings Call February 16, 2026 6:01 PM ESTCompany ParticipantsStephen Mikkelsen - Group CEO, Director & MDWarrick R.
Pfizer Inc. today announced positive topline progression-free (PFS) survival results from Cohort 3, a separate randomized cohort of the pivotal BREAKWATER trial, evaluating BRAFTOVI® (encorafenib) in ...
Johnson & Johnson today announced the U.S. Food and Drug Administration (FDA) has approved a new, simplified monthly dosing schedule* for RYBREVANT FASPROtm (amivantamab and hyaluronidase-lpuj). When ...
Get CBSE Board 2026 LIVE updates on Class 10 Maths paper reviews. Check students' feedback, difficulty level, and expert ...
Monthly dosing reduces treatment visits while maintaining established safety and efficacy1,2 Builds on RYBREVANT FASPRO FDA approval to deliver the simplest and fastest ...
Igbinoghene recorded 35 total tackles (22 solo), including 1.0 sacks, while also adding five passes defensed and 191 kickoff-return yards over 15 contests during the 2025 regular season. Igbinoghene ...